Functional RNA elements in the human genome
人类基因组中的功能性RNA元件
基本信息
- 批准号:9381421
- 负责人:
- 金额:$ 69.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-06-01 至 2020-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAlternative SplicingAreaBindingBinding ProteinsBinding SitesBioinformaticsBiologyChromatinClustered Regularly Interspaced Short Palindromic RepeatsCouplingDNADNA Polymerase IIDNA-Directed RNA PolymeraseData SetDevelopmentDiseaseDissectionElementsEpigenetic ProcessEventFundingGene ExpressionGenesGenetic TranscriptionGenomic approachGenomicsGoalsGrantHuman GenomeIndividualLeadMammalian CellMass Spectrum AnalysisMessenger RNAMetabolismMethodologyMethodsMolecularNational Human Genome Research InstituteNuclear ExportNuclear PorePathologyPathway AnalysisPathway interactionsPatternPhasePolyadenylationPositioning AttributeProductivityProtein AnalysisProteinsPublicationsRANGAP1 geneRNARNA BindingRNA ProcessingRNA Recognition MotifRNA SplicingRNA analysisRNA-Binding ProteinsRNA-Protein InteractionReactionRecruitment ActivityRegulationRegulatory PathwayReproducibilityResearchRoleSequence HomologySeriesTestingTranscriptional RegulationUntranslated RNAZinc Fingerscomputerized toolseffective therapygenome-widegenomic RNAgenomic toolshuman diseaseinfancyinnovationinsightmRNA Precursormammalian genomenovelnovel strategiesnucleocytoplasmic transportprotein profilingprotein protein interactionscreeningtechnological innovationtranscription factortranscriptometreatment strategy
项目摘要
Project Summary
This proposal seeks competitive renewal of a multi-PI project (Fu and Yeo), which aims to use global
approaches to elucidate the regulatory principles of RNA binding proteins (RBPs) in mammalian genomes.
Built upon our accomplishments in the past funding cycle, we propose to leverage the powerful experimental
and computational tools we have developed to pursue four specific aims. In Aim 1, we will couple gain- and
lost-of-function multi-target screens to deduce regulatory pathways at both splicing and polyadenylation levels.
We will focus on determining the specific function of different RNA polymerase II (Pol II) subunits, rather than
by the Pol II CTD alone, in the recruitment of RNA processing machineries for co-transcriptional RNA
processing. In Aim 2, we will develop a general strategy for systematic identification of chromatin-associated
RBPs to determine direct contribution of some RBPs to transcription and co-transcriptional RNA processing
reactions. We will concentrate our efforts in dissecting a potential new pathway in epigenetic control of
alternative splicing as well as broader roles of specific RBPs in direct transcriptional control. In Aim 3, we will
use a novel strategy for identification and characterization of non-canonical RBPs. Focusing on a large
number of newly identified finger zinc (Znf) proteins, we propose to determine their roles in binding to both
DNA and RNA and deduce their transcriptome-wide interactions with RNA. We also propose to pursue a
specific paradigm in this aim on a newly identified RBP known to associate with the nuclear pore to determine
its role in selective mRNA nuclear export, which is pertinent to an ALS-regulated disease pathology.
Combined, we believe that this comprehensive, interconnected, and hypothesis-driven research plan will
greatly advance our understanding of regulated RNA processing and associated disease mechanisms.
项目摘要
该提案寻求多PI项目(Fu和Yeo)的竞争性更新,该项目旨在使用全球
阐明哺乳动物基因组中RNA结合蛋白(RBP)调控原理的方法。
基于我们在过去的资助周期中取得的成就,我们建议利用强大的实验性
和计算工具,我们已经开发了追求四个具体目标。在目标1中,我们将增益和
功能丧失的多靶筛选以推断剪接和多聚腺苷酸化水平的调节途径。
我们将集中在确定不同的RNA聚合酶II(Pol II)亚基的具体功能,而不是
通过单独的Pol II CTD,在共转录RNA的RNA加工机器的募集中,
处理.在目标2中,我们将开发一种系统鉴定染色质相关的
RBP以确定一些RBP对转录和共转录RNA加工的直接贡献
反应.我们将集中我们的努力解剖一个潜在的新途径,在表观遗传控制,
选择性剪接以及特定RBP在直接转录控制中的更广泛作用。在目标3中,我们
使用一种新的策略来识别和表征非规范RBP。专注于大型
一些新发现的指状锌(Znf)蛋白,我们建议确定它们的作用,结合两者
DNA和RNA,并推导出它们与RNA的转录组范围内的相互作用。我们亦建议推行一项
在这个目标的特定范例上,新鉴定的已知与核孔相关的RBP确定
它在选择性mRNA核输出中的作用,这与ALS调节的疾病病理学有关。
结合起来,我们相信,这一全面的,相互关联的,假设驱动的研究计划将
极大地推进了我们对RNA加工调控和相关疾病机制的理解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
XIANG-DONG FU其他文献
XIANG-DONG FU的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('XIANG-DONG FU', 18)}}的其他基金
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8734415 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9081584 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8915157 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
8647698 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
Synergestic roles of SRSF2 and RUNX1 in blood cell development and pathology
SRSF2 和 RUNX1 在血细胞发育和病理学中的协同作用
- 批准号:
9310249 - 财政年份:2013
- 资助金额:
$ 69.75万 - 项目类别:
FUNCTION AND REGULATION OF THE HUMAN SPLICING FACTOR SC35
人类剪接因子 SC35 的功能和调控
- 批准号:
7845881 - 财政年份:2009
- 资助金额:
$ 69.75万 - 项目类别:
相似海外基金
Alternative splicing of Grin1 controls NMDA receptor function in physiological and disease processes
Grin1 的选择性剪接控制生理和疾病过程中的 NMDA 受体功能
- 批准号:
488788 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Operating Grants
RBFOX2 deregulation promotes pancreatic cancer progression through alternative splicing
RBFOX2 失调通过选择性剪接促进胰腺癌进展
- 批准号:
10638347 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Long Noncoding RNA H19 Mediating Alternative Splicing in ALD Pathogenesis
长非编码 RNA H19 介导 ALD 发病机制中的选择性剪接
- 批准号:
10717440 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Using proteogenomics to assess the functional impact of alternative splicing events in glioblastoma
使用蛋白质基因组学评估选择性剪接事件对胶质母细胞瘤的功能影响
- 批准号:
10577186 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Alternative splicing regulation of CLTC in the heart
心脏中 CLTC 的选择性剪接调节
- 批准号:
10749474 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Nitric oxide as a novel regulator of alternative splicing
一氧化氮作为选择性剪接的新型调节剂
- 批准号:
10673458 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Alternative splicing as an evolutionary driver of phenotypic plasticity
选择性剪接作为表型可塑性的进化驱动力
- 批准号:
2884151 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Studentship
Rescuing SYNGAP1 haploinsufficiency by redirecting alternative splicing
通过重定向选择性剪接挽救 SYNGAP1 单倍体不足
- 批准号:
10660668 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
CAREER: Mechanotransduction, transcription, and alternative splicing in cell biology
职业:细胞生物学中的机械转导、转录和选择性剪接
- 批准号:
2239056 - 财政年份:2023
- 资助金额:
$ 69.75万 - 项目类别:
Continuing Grant
Investigating the role of alternative splicing in the islets of Langerhans in developing diabetes.
研究朗格汉斯岛中选择性剪接在糖尿病发生中的作用。
- 批准号:
468851650 - 财政年份:2022
- 资助金额:
$ 69.75万 - 项目类别:
Research Grants














{{item.name}}会员




